Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,992,394
+$150,050 QoQ
Shares Held
7,845
+4.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#2,349
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026S.A. Mason LLC holds $12,379,971 across 9 Drug Manufacturers - General names. JNJ ranks #4 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
12,339 | $3,104,985 | |
| 2 | LLY |
ELI LILLY & Co
|
2,467 | $2,958,994 | |
| 3 | AMGN |
Amgen Inc
|
6,408 | $2,320,464 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
7,845 | $1,992,394 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,968 | $638,388 | |
| 6 | NVS |
Novartis AG
|
4,040 | $633,148 | |
| 7 | NVO |
Novo Nordisk A S
|
6,278 | $300,967 | |
| 8 | PFE |
Pfizer Inc
|
9,104 | $219,224 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,992,394 | 7,845 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,842,344 | 7,537 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,557,919 | 7,528 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,395,841 | 7,528 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,160,747 | 7,599 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,236,171 | 7,454 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,070,621 | 7,403 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,204,916 | 7,435 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,085,676 | 7,428 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1,173,769 | 7,420 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,144,672 | 7,303 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,181,519 | 7,586 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,253,482 | 7,573 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $1,173,815 | 7,573 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,341,833 | 7,596 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $1,240,065 | 7,591 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,346,413 | 7,585 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $1,357,581 | 7,660 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,266,602 | 7,404 | Shares | Sole | 2022-01-04 | |
| 2021-09-30 | $1,194,938 | 7,399 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,139,341 | 6,916 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $1,136,151 | 6,913 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,087,653 | 6,911 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,033,822 | 6,944 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $990,457 | 7,043 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $962,625 | 7,341 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||